Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Treatment
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 25, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Grenvil Gracias1, Scott Garrison2, G Michael Allan3
1Resident at the University of Alberta in Edmonton.
No abstract available in PubMed .